GUIDELINE for QUALIFICATION & MANAGEMENT …

active pharmaceutical ingredients committee (apic) guideline for qualification & management of contract quality control laboratories 10 january 2012

  Management, Contract

Quality Agreement for Laboratories Guideline Templates

A Quality Agreement under the scope of this guideline is a legally binding agreement that is mutually negotiated and concluded between (the Quality Departments of) the service requestor and the Quality responsible at the service providing laboratory.

  Laboratory, Agreement

GUIDANCE ON ASPECTS OF CLEANING ... - …

confidential 1 revision september 2016 active pharmaceutical ingredients committee (apic) guidance on aspects of cleaning validation in …

  Pharmaceutical, Active, Ingredients, Committees, Apic, Active pharmaceutical ingredients committee

ACTIVE PHARMACEUTICAL INGREDIENTS …

APIC_eCTD How to Do Page 4 INTRODUCTION eCTD is a topic of increasing interest in the pharmaceutical environment. In the past, the main focus for regulatory authorities was eCTD submissions sent via MAAs.

  Pharmaceutical, Active, Ingredients, Active pharmaceutical ingredients, Apic

Guidance on aspects of cleaning validation in active ...

Cleaning Validation Guidance 3 1.0 Foreword This document has been prepared by the cleaning validation task force within the active …

  Validation, Guidance, Validation guidance

Registered Starting Material Auditing Guide - …

AIDE MEMOIRE FOR REGISTERED STARTING MATERIAL AUDITS 1) APIC Guide for Auditing Registered Starting Material Manufacturers * tbi = to be implemented Page 2 / 23 ** Procedure, SOP, OI, memo, notes (personal), Q-manual

  Auditing

Guidance on Handling of Insoluble Matter and …

APIC Guidance on Insoluble Matter and Foreign Particles in APIs Page 3 of 19 Table of contents 1. Acknowledgements 2. Introduction and Purpose

ACTIVE PHARMACEUTICAL INGREDIENTS COMMITTEE …

- Stefaan Van De Velde, Ajinomoto Bio-Pharma Services, Belgium A revision of the guidance document was done in 2016 to bring it in line with the European Medicines Agency Guidance on use of Health Based data on setting health-based exposure limits for determining safe threshold values for the cleaning1. The main changes were

  Pharmaceutical, Active, Ingredients, Committees, Active pharmaceutical ingredients committee, Pharma

“How to do” Document

The explanatory notes in this guide are the views of The Active Pharmaceutical Ingredients Commit- tee (APIC) and not necessarily those of the European Commission or WHO. This document does not intend to provide an exhaustive list of how to comply with the require-

  Notes, Pharmaceutical, Document, Explanatory notes, Explanatory, How to do document

Practical risk-based guide for managing data integrity

Assign GxP data to a specific category based on a . severity assessment (refer to section 4.1) Create a . profile. of each . system. based on the way GxP data is handled by that system (e.g. data generation, storage, processing, transfer or a combination thereof) and assign a category to the system based on its profile; (refer to section 4.2)

  Based, Managing

ICH QUALITY IMPLEMENTATION WORKING GROUP …

ICH Q8/Q9/Q10 Implementation Section 1. INTRODUCTION The ICH Quality Implementation Working Group (Q-IWG) has prepared ‘Points to Consider’ covering topics relevant to the implementation of ICH Q8(R2), Q9 and Q10, which supplement the existing Questions & Answers and workshop training materials already produced by this group.

  Quality, Implementation, Group, Points, Working, Ich quality implementation working group

Overview ICH GCP E6(R2) Integrated Addendum

The ICH convened an expert working group to create an addendum to the existing E6 guideline. The expert working group was consisted of ICH members from both industry and regulatory agencies, as well as observers, to address current research topics like quality by design, quality risk management, and focus on

  Quality, Group, Working, Working group

MedDRA TERM SELECTION: POINTS TO CONSIDER

This MedDRA Term Selection: Points to Consider (MTS:PTC) document is an ICH-endorsed guide for MedDRA users. It is updated annually in step with the March release of MedDRA (starting with MedDRA Version 23.0) and is support documentation for MedDRA. It was developed and is maintained by a working group charged by the ICH Management Committee.

  Group, Points, Working, Working group, Meddra

Implementation Process Article 5(3) Nitrosamine

contact points as outlined on the EMA and CMDh websites. If the N-nitrosamine(s) identified exceed(s) the AI limit based on the ICH M7 principles, an investigation report should be submitted as part of the step 2 response (see chapter 3.1. for further

  Implementation, Points

H A N D B O O K - WHO

iii FOREWORD In order to assist countries in conducting non-clinical research and drug development, TDR developed a Good Laboratory Practices (GLP) series in 2001, comprising a GLP Handbook as well as GLP Training manuals for trainers and trainees. The demand for this series was so substantial that it became one of the most frequent “hits”